Skip to content
★ Sign in to follow
AF

Anna Frostegård

Executive
Annexin Pharmaceuticals AB
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 05 Mar 2020 for Annexin Pharmaceuticals AB, €153k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Anna Frostegård: trading record in brief

One trade, one date: on 5 March 2020, Anna Frostegård disclosed a transaction of €153k in Annexin Pharmaceuticals AB. No broader history exists yet. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Anna Frostegård

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ●
    Chief Medical and Scientific OfficerExecutivesAnnexin Pharmaceuticals AB
    2M SEK0FI-SE
    1,404,972 shares@ SEK 1.15100.0% of flowBTA (betald tecknad aktie)ISIN SE0013748894FI:csv-bf8a6e82fedfad0f55f8

1 of 1 declaration